NRx and Israel Developing Covid-19 Vaccine to Attack Variants

The video discusses the challenges of COVID-19 vaccine effectiveness due to virus mutations and the need for booster shots. It highlights vaccine hesitancy among athletes, particularly due to concerns about myocarditis, despite the higher risks of COVID-19. The video also covers ongoing efforts in developing treatments and vaccines targeting new variants, including a partnership with Israel to address these challenges.

Why is there a need for updated COVID-19 vaccines?

• People are not getting vaccinated.

• The vaccines are causing severe side effects.

• The current vaccines are too expensive.

• The virus is mutating, reducing vaccine effectiveness.

What is a major concern for athletes regarding the COVID-19 vaccine?

• Vaccine costs.

• Vaccine storage requirements.

• Fear of myocarditis.

• Lack of access to vaccines.

What is the risk comparison between COVID-19 and the vaccine?

• The vaccine risk is higher than COVID-19.

• COVID-19 risk is higher than the vaccine.

• Both have equal risks.

• Neither has any risk.

What is the purpose of the treatment under FDA review?

• To replace vaccines.

• To prevent COVID-19 infection.

• To help ICU patients with COVID-19.

• To cure all viral infections.

What is the focus of the new vaccine being developed with Israel?

• To eliminate the need for boosters.

• To increase vaccine shelf life.

• To reduce vaccine costs.

• To target COVID-19 variants.